1. Antilirium
2. Eserine Salicylate
3. Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, Methylcarbamate (ester), (3as-cis)-, Mono(2-hydroxybenzoate)
1. 57-64-7
2. Eserine Salicylate
3. Isopto Eserine
4. Physostigmine Monosalicylate
5. Nsc-757275
6. 57-64-7 (salicylate)
7. Mls000028388
8. 2046zro9vu
9. Chebi:48883
10. Smr000058606
11. Physostigmine (salicylate)
12. Benzoic Acid, 2-hydroxy-, Compd. With (3as,8ar)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl Methylcarbamate (1:1)
13. Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, Methylcarbamate (ester), (3as-cis)-, Mono(2-hydroxybenzoate)
14. (3as,8ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl Methylcarbamate 2-hydroxybenzoate
15. [(3ar,8bs)-3,4,8b-trimethyl-2,3a-dihydro-1h-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate;2-hydroxybenzoic Acid
16. Physostol Salicylate
17. Sr-01000075341
18. Unii-2046zro9vu
19. Physostigminesalicylate
20. Ccris 3405
21. Physostigmine Salicylate [jan]
22. Physostigmine, Salicylate (1:1)
23. Antilirium (tn)
24. Ar-44
25. Benzoic Acid, 2-hydroxy-, Compd. With (3as,8ar)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl N-methylcarbamate (1:1)
26. Benzoic Acid, 2-hydroxy-, Compd. With (3as,8ar)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl N-methylcarbamate (1:1)
27. Einecs 200-343-8
28. Physostigmine Salicylate [usp:jan]
29. Eserine Monosalicylate
30. Physostigmini Salicylas
31. Tl-1380
32. Spectrum_000223
33. Opera_id_194
34. Rcra Waste No. P188
35. Salicylic Acid, Compd. With Physostigmine (1:1)
36. Schembl41555
37. Kbioss_000703
38. Divk1c_000339
39. Spectrum1500486
40. Chembl338975
41. Hms501a21
42. Kbio1_000339
43. Kbio2_000703
44. Kbio2_003271
45. Kbio2_005839
46. Dtxsid80883232
47. Ninds_000339
48. Hms1920h12
49. Hms2091p16
50. Hms2235g19
51. Pharmakon1600-01500486
52. Bcp25378
53. Hy-b1266
54. Physostigmine Salicylate (jan/usp)
55. Ccg-39918
56. Nsc757275
57. Physostigmine Salicylate [mi]
58. Akos037515711
59. Nsc 757275
60. Sdccgmls-0002925.p003
61. Idi1_000339
62. Physostigmine Salicylate [mart.]
63. Physostigmine Salicylate [vandf]
64. Ncgc00024464-02
65. Physostigmine Salicylate [usp-rs]
66. Physostigmine Salicylate [who-dd]
67. Physostigmine Salicylate [who-ip]
68. Eserine Salicylate Salt, >=97.0% (n)
69. Cs-0013051
70. Physostigmini Salicylas [who-ip Latin]
71. D02418
72. Physostigmine Salicylate [ep Monograph]
73. Physostigmine Salicylate [usp Monograph]
74. A903540
75. Sr-01000075341-3
76. Sr-01000075341-5
77. Sr-01000075341-7
78. Q27121383
79. Physostigmine Salicylate, European Pharmacopoeia (ep) Reference Standard
80. Physostigmine Salicylate, United States Pharmacopeia (usp) Reference Standard
81. (3as,8ar)-1,3a,8-trimethyl-5-(methylcarbamoyloxy)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indolium Salicylate
82. [(3ar,8bs)-3,4,8b-trimethyl-2,3,3a,4-tetrahydro-1h-pyrrolo[2,3-b]indole-3,4-diium-7-yl] N-methylcarbamate;2-oxidobenzoate
83. Benzoic Acid, 2-hydroxy-, Compd. With (3as-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl Methylcarbamate Ester (1:1)
| Molecular Weight | 413.5 g/mol |
|---|---|
| Molecular Formula | C22H27N3O5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 413.19507097 g/mol |
| Monoisotopic Mass | 413.19507097 g/mol |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 535 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
LOOKING FOR A SUPPLIER?
